Cardiorenal Outcomes and Mortality After SGLT2 Inhibitor Initiation in Patients With Type 2 Diabetes and Percutaneous Coronary Intervention History
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiorenal outcomes and mortality after sodium-glucose cotransporter-2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history
Diabetes Obes Metab 2024 Apr 21;[EPub Ahead of Print], JH Kim, YS Lyu, B Kim, MK Kim, SY Kim, KH Baek, KH Song, K Han, HS KwonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.